Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helene Blasco

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Acta Haematologica|October 11, 2014
Decisional early interim (18)F-fluoro-2-deoxy-D-glucose positron emission tomography after two cycles of chemotherapy in de novo Hodgkin lymphomaAurore Iltis, Veronique Eder, Helene Blasco, et al.
Frontiers in Neurology|August 28, 2020
Is There a Role for Vitamin D in Amyotrophic Lateral Sclerosis? A Systematic Review and Meta-AnalysisDébora Lanznaster, Theodora Bejan-Angoulvant, Jorge Gandía, et al.
Clinical Pharmacokinetics|March 11, 2010
Predictions of metabolic drug-drug interactions using physiologically based modelling: Two cytochrome P450 3A4 substrates coadministered with ketoconazole or verapamilNathalie Perdaems, Helene Blasco, Cedric Vinson, et al.
Journal of the American Geriatrics Society|August 25, 2016
Inborn Errors of Metabolism in Elderly AdultsAudrey-Anne Fouchard, Philippe Corcia, Christine Allais, et al.
European Journal of Neurology|September 30, 2022
Comparison between PFN1 and SOD1 mutations in amyotrophic lateral sclerosisPhilippe Corcia, Pascal Lejeune, Patrick Vourc'h, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 6, 2017
A novel mutation of the C-terminal amino acid of FUS (Y526C) strengthens FUS gene as the most frequent genetic factor in aggressive juvenile ALSPhilippe Corcia, Veronique Danel, Arnaud Lacour, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 20, 2009
Quantification of coproporphyrin isomers I and III in urine by HPLC and determination of their ratio for investigations of multidrug resistance protein 2 (MRP2) function in humansRenaud Respaud, Isabelle Benz-de Bretagne, Helene Blasco, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|August 10, 2012
Amyotrophic lateral sclerosis: a hormonal condition?Helene Blasco, Anne-Marie Guennoc, Charlotte Veyrat-Durebex, et al.
Expert Review of Neurotherapeutics|June 26, 2020
Understanding and managing metabolic dysfunction in Amyotrophic Lateral SclerosisHelene Blasco, Debora Lanznaster, Charlotte Veyrat-Durebex, et al.
Translational Psychiatry|April 23, 2021
SHR/NCrl rats as a model of ADHD can be discriminated from controls based on their brain, blood, or urine metabolomesCamille Dupuy, Pierre Castelnau, Sylvie Mavel, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Acta Haematologica|October 11, 2014
Decisional early interim (18)F-fluoro-2-deoxy-D-glucose positron emission tomography after two cycles of chemotherapy in de novo Hodgkin lymphomaAurore Iltis, Veronique Eder, Helene Blasco, et al.
Frontiers in Neurology|August 28, 2020
Is There a Role for Vitamin D in Amyotrophic Lateral Sclerosis? A Systematic Review and Meta-AnalysisDébora Lanznaster, Theodora Bejan-Angoulvant, Jorge Gandía, et al.
Clinical Pharmacokinetics|March 11, 2010
Predictions of metabolic drug-drug interactions using physiologically based modelling: Two cytochrome P450 3A4 substrates coadministered with ketoconazole or verapamilNathalie Perdaems, Helene Blasco, Cedric Vinson, et al.
Journal of the American Geriatrics Society|August 25, 2016
Inborn Errors of Metabolism in Elderly AdultsAudrey-Anne Fouchard, Philippe Corcia, Christine Allais, et al.
European Journal of Neurology|September 30, 2022
Comparison between PFN1 and SOD1 mutations in amyotrophic lateral sclerosisPhilippe Corcia, Pascal Lejeune, Patrick Vourc'h, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 6, 2017
A novel mutation of the C-terminal amino acid of FUS (Y526C) strengthens FUS gene as the most frequent genetic factor in aggressive juvenile ALSPhilippe Corcia, Veronique Danel, Arnaud Lacour, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 20, 2009
Quantification of coproporphyrin isomers I and III in urine by HPLC and determination of their ratio for investigations of multidrug resistance protein 2 (MRP2) function in humansRenaud Respaud, Isabelle Benz-de Bretagne, Helene Blasco, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|August 10, 2012
Amyotrophic lateral sclerosis: a hormonal condition?Helene Blasco, Anne-Marie Guennoc, Charlotte Veyrat-Durebex, et al.
Expert Review of Neurotherapeutics|June 26, 2020
Understanding and managing metabolic dysfunction in Amyotrophic Lateral SclerosisHelene Blasco, Debora Lanznaster, Charlotte Veyrat-Durebex, et al.
Translational Psychiatry|April 23, 2021
SHR/NCrl rats as a model of ADHD can be discriminated from controls based on their brain, blood, or urine metabolomesCamille Dupuy, Pierre Castelnau, Sylvie Mavel, et al.
Pageof 2